Pfizer is betting big on cancer drugs to turn business around after Covid decline – here’s what to know
The pharmaceutical giant has been trying to shore up investor sentiment after its shares fell more than 40% in 2023.
Read MoreThe pharmaceutical giant has been trying to shore up investor sentiment after its shares fell more than 40% in 2023.
Read MoreTwo investment professionals reveal their top stocks and funds in this alternative developed market. Source link
Read MoreIt's still unclear which drugs Medicare will select, but several companies have revealed in court filings that four of their
Read MoreThe Wall Street bank is bullish as the broad MSCI Asia Pacific equities index has entered a new bull market,
Read MorePrices have shot up in many countries, and investors could do well looking at stocks that pay out good dividends,
Read More